Company / Operating Income
TELA Bio, Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$44.1M
FY2025
5-year range
-$44.1M / -$19.2M
FY2021-FY2025
Trend
-13.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 6 consecutive years, from -$17M in FY2019 to -$44M in FY2025.
Based on SEC 10-K filings.
-$44M in FY2025.
Declined from -$29M to -$44M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TELA Bio, Inc.'s operating income has declined for 6 consecutive years.
- In FY2025, operating income decreased 13.0% year-over-year.
- Peak operating income was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$44.1M | -13.0% |
| FY2024 | -$39.0M | -32.4% |
| FY2023 | -$29.5M | -16.5% |
| FY2022 | -$25.3M | -31.9% |
| FY2021 | -$19.2M | -7.8% |
| FY2020 | -$17.8M | -5.1% |
| FY2019 | -$16.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026